Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma
1Department of Dermatology, St Louis University Health Science Center, Missouri, USA.
Background:
Keratoacanthomas are characterized by initial rapid enlargement followed by clinical regression. A series of cyclin and cyclin-dependent kinase complexes regulate cell cycle progression. p27(kip) inhibits a variety of cyclin-cyclin-dependent kinase complexes in vitro and may act to hold eukaryotic cells in a quiescent state (G0).
Objective:
We examined expanding and regressing keratoacanthomas for expression of p27(kip).
Methods:
An immunohistochemical method was used to visualize and count p27(kip)-labeled cells in 5 expanding and 15 regressing keratoacanthomas.
Results:
In normal epidermis p27(kip) was found overlying the nuclei of suprabasilar keratinocytes. In expanding keratoacanthoma there was little expression of p27(kip) in nuclei of atypical keratinocytes composing the tumor (1.25 +/- 2.1 labeled cells per high-power field); in regressing keratoacanthoma the nuclei of most suprabasilar keratinocytes in atypical tumor aggregates contained p27(kip) (55.1 +/- 28.6 labeled cells per high-power field). The difference was significant at P values of less than.001.
Conclusion:
The identification of p27(kip) in regressing keratoacanthoma but not in expanding keratoacanthoma suggests that p27(kip) may be playing a role in promoting regression of keratoacanthoma and is a potential target for pharmacologic intervention.
Insights
p27(kip) protein is present in regressing keratoacanthomas but not expanding ones. This suggests p27(kip) may promote keratoacanthoma regression and could be a therapeutic target.
Area of Science:
- Dermatology
- Oncology
- Cell Biology
Background:
- Keratoacanthomas exhibit rapid growth followed by spontaneous regression.
- Cell cycle regulation involves cyclin and cyclin-dependent kinase complexes.
- p27(kip) is an inhibitor of cyclin-dependent kinase complexes, potentially inducing cell quiescence.
Purpose of the Study:
- To investigate the expression of p27(kip) in both expanding and regressing keratoacanthomas.
- To determine the role of p27(kip) in the regression process of keratoacanthomas.
Main Methods:
- Immunohistochemical analysis was employed to detect and quantify p27(kip) expression.
- The study included samples from 5 expanding and 15 regressing keratoacanthomas.
Main Results:
- p27(kip) was observed in the nuclei of suprabasilar keratinocytes in normal epidermis.
- Expanding keratoacanthomas showed minimal p27(kip) expression in atypical keratinocytes (1.25 cells/HPF).
- Regressing keratoacanthomas demonstrated significant p27(kip) expression in atypical keratinocytes (55.1 cells/HPF), with P < .001.
Conclusions:
- The presence of p27(kip) in regressing keratoacanthomas, contrasted with its absence in expanding ones, implicates it in the regression mechanism.
- p27(kip) emerges as a potential therapeutic target for promoting keratoacanthoma regression.
Related Concept Videos
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
Inhibition of CDK Activity

